LungVax vaccine uses DNA technology to prevent lung cancer

Mar 21 2024Cancer Research UK Developed by scientists from the University of Oxford, the Francis Crick Institute and University College London, the LungVax vaccine uses technology similar to the highly successful Oxford/AstraZeneca COVID-19 vaccine.

The LungVax vaccine will carry a strand of DNA which trains the immune system to recognize these neoantigens on abnormal lung cells. The LungVax vaccine will then activate the immune system to kill these cells and stop lung cancer. Kidani Professor of Immuno-oncology at the University of Oxford and research lead for the LungVax project, Professor Tim Elliott, said:

Related StoriesProfessor of Experimental Oncology at the University of Oxford and founder of the LungVax project, Professor Sarah Blagden, said: Professor Mariam Jamal-Hanjani of University College London and the Francis Crick Institute, who will be leading the LungVax clinical trial, said:

Education Education Latest News, Education Education Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The Sims 4 University cheats – enroll in university, learn skills, and earn a degreeAre you looking for all the Sims 4 University cheats? Help you Sims survive college life and get a degree quickly.
Source: VideoGamerCom - 🏆 83. / 55 Read more »

Lit from within: How tiny wireless bulbs could revolutionize clinical health careResearchers from the University of St Andrews and the University of Cologne have developed a new device platform that allows for smaller wireless light sources to be placed within the human body.
Source: medical_xpress - 🏆 101. / 51 Read more »

Blood-based marker developed to identify sleep deprivationA blood test that can accurately detect when someone has not slept for 24 hours has been developed by experts at Monash University, in Australia, and the University of Birmingham, in the UK.
Source: medical_xpress - 🏆 101. / 51 Read more »